Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2: genes and variants
Explore variant evidence for Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 across 3 analyzed proteins (AKT3, CCND2, PIK3R2). Linked ClinVar records include 21 pathogenic or likely pathogenic variants, 42 variants of uncertain significance and 9 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2
AKT3: RAC-gamma serine/threonine-protein kinase
It is especially important for growth and survival signaling in the developing brain. Activating mosaic or germline variants can cause megalencephaly and cortical malformation syndromes, while loss-of-function variants can be associated with microcephaly and neurodevelopmental impairment.
8 ClinVar pathogenic / likely pathogenic and 33 uncertain variants in AKT3 have source records linked to Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2. Association strength is not clinical gene validity.
CCND2: G1/S-specific cyclin-D2
It promotes G1-to-S cell-cycle progression through activation of CDK4 and CDK6 and is important in proliferating neural and endocrine tissues. Activating germline variants can cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, while overexpression occurs in several cancers.
7 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in CCND2 have source records linked to Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2. Association strength is not clinical gene validity.
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta
The p85β regulatory subunit of class IA phosphoinositide 3-kinase, which helps control PI3K–AKT signaling and cell growth. Specific activating variants cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.
6 ClinVar pathogenic / likely pathogenic and 15 uncertain variants in PIK3R2 have source records linked to Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2. Association strength is not clinical gene validity.
Where Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 variants cluster
- PIK3R2 SH2 1 (positions 330–425): 5 of 6 ClinVar pathogenic / likely pathogenic variants, 6.3× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CCND2 T280N | 280 | Pathogenic / likely pathogenic (★★) | |
| CCND2 P281S | 281 | Pathogenic / likely pathogenic (★★) | |
| AKT3 D322N | 322 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| CCND2 T280A | 280 | Pathogenic / likely pathogenic (★★) | |
| CCND2 T280P | 280 | Pathogenic / likely pathogenic (★★) | |
| CCND2 V284E | 284 | Pathogenic / likely pathogenic (★★) | |
| PIK3R2 K376E | 376 | SH2 1 | Pathogenic / likely pathogenic (★★) |
| CCND2 P281L | 281 | Pathogenic / likely pathogenic (★) | |
| AKT3 D322Y | 322 | Protein kinase | Pathogenic / likely pathogenic (★) |
| AKT3 W79C | 79 | PH | Pathogenic / likely pathogenic (★) |
| AKT3 K180E | 180 | Protein kinase | Pathogenic / likely pathogenic (★) |
| AKT3 V183D | 183 | Protein kinase | Pathogenic / likely pathogenic (★) |
| PIK3R2 W330G | 330 | SH2 1 | Pathogenic / likely pathogenic (★) |
| PIK3R2 F352L | 352 | SH2 1 | Pathogenic / likely pathogenic (★) |
| PIK3R2 N561D | 561 | Pathogenic / likely pathogenic (★) | |
| AKT3 N229S | 229 | Protein kinase | Pathogenic / likely pathogenic (★) |
| CCND2 T280I | 280 | Pathogenic / likely pathogenic | |
| AKT3 N321K | 321 | Protein kinase | Pathogenic / likely pathogenic |
| AKT3 L77H | 77 | PH | Pathogenic / likely pathogenic |
| PIK3R2 L401P | 401 | SH2 1 | Pathogenic / likely pathogenic |
| PIK3R2 G385R | 385 | SH2 1 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| CCND2 P281R | 281 | Conflicting reports (★) | +7: 7 other pathogenic changes within 3 positions; P281L at the same position is pathogenic; seen in 2e-06 of gnomAD DNA copies; REVEL 0.908 | |
| AKT3 V183A | 183 | Protein kinase | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; V183D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.92 |
Which prediction tools work for Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 93 out of 100
- PolyPhen-2: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 92 out of 100
- CATVariant: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 84 out of 100
- MetaSVM: 83 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 78 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2
- Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes, also linked to AKT3 and PIK3R2
- Diabetes mellitus, also linked to CCND2
- Multiple myeloma, also linked to PIK3R2
- Lennox-Gastaut syndrome, also linked to CCND2
Frequently asked questions
Which genes have records linked to Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2?
This view contains 3 analyzed proteins: AKT3, CCND2, PIK3R2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 21 pathogenic or likely pathogenic variants, 42 variants of uncertain significance and 9 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 2 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 91 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center